Amgen (Nasdaq: AMGN) has completed construction of a $550 million drug manufacturing facility in the Wake County town.

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

The New Haven facility will offer a range of services, including clinical trial services, advanced imaging services, imaging analysis and radiotracer manufacturing. Founded in 2012, Mitro Biotech ...

Kyowa Hakko Bio is selling its amino acid businesses, including Cape Girardeau's BioKyowa facility, to China's MEIHUA. The transition promises job stability and unchanged production levels for the U.S ...

The newly inaugurated THSTI Ferret Research Facility represents a significant milestone in India’s biomedical and pandemic ...

Windlas Biotech Limited, a leading Indian pharmaceutical CDMO, announced today that its new injectable manufacturing facility has received Good Manufacturing Practices (GMP) certification from ...